Efficacy of Early Intensive ROsuvastatin Therapy in Patients With ST-segment Elevation Myocardial Infarction Undergoing PrimARY Percutaneous Coronary Intervention (the ROSEMARY Trial).

Trial Profile

Efficacy of Early Intensive ROsuvastatin Therapy in Patients With ST-segment Elevation Myocardial Infarction Undergoing PrimARY Percutaneous Coronary Intervention (the ROSEMARY Trial).

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Nov 2017

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms ROSEMARY
  • Most Recent Events

    • 16 Apr 2014 Results published in the American Journal of Cardiology.
    • 04 Mar 2014 Planned End Date changed from 1 Jun 2012 to 1 Mar 2015 as reported by ClinicalTrials.gov.
    • 04 Sep 2013 Primary endpoint 'Myocardial-infarct-size' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top